MARGUTTI, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 4.029
EU - Europa 1.533
AS - Asia 883
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
SA - Sud America 1
Totale 6.449
Nazione #
US - Stati Uniti d'America 4.024
DE - Germania 620
CN - Cina 500
UA - Ucraina 364
TR - Turchia 263
GB - Regno Unito 128
SE - Svezia 108
SG - Singapore 100
RU - Federazione Russa 97
IT - Italia 95
FI - Finlandia 86
BE - Belgio 12
IR - Iran 12
FR - Francia 10
IN - India 6
RO - Romania 4
CA - Canada 3
IE - Irlanda 3
CH - Svizzera 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EU - Europa 1
HR - Croazia 1
KZ - Kazakistan 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
Totale 6.449
Città #
Woodbridge 520
Fairfield 473
Jacksonville 421
Chandler 408
Houston 317
Ann Arbor 260
Ashburn 226
Wilmington 159
Seattle 153
Izmir 144
Cambridge 139
Beijing 133
Nanjing 104
Princeton 80
Addison 71
Singapore 58
San Diego 55
Boardman 51
Nanchang 47
Milan 42
Shanghai 35
Hebei 33
New York 27
Shenyang 23
Tianjin 23
Changsha 22
Jiaxing 20
San Mateo 19
Bremen 18
Dearborn 17
Brussels 12
Leawood 12
Augusta 11
Jinan 11
Washington 11
Düsseldorf 10
Helsinki 10
Monmouth Junction 10
Carrara 9
London 9
Mountain View 9
Ningbo 9
Ardabil 8
Los Angeles 7
Norwalk 7
Orange 7
Zhengzhou 7
Falls Church 6
Taizhou 6
Verona 6
Auburn Hills 5
Des Moines 5
Kunming 5
Guangzhou 4
Haikou 4
Hefei 4
Hounslow 4
Changchun 3
Hebden Bridge 3
Indiana 3
Philadelphia 3
Redwood City 3
Tehran 3
Dublin 2
Frankfurt am Main 2
Genoa 2
Hanover Park 2
Kilburn 2
Mumbai 2
Thunder Bay 2
Alexandria 1
Almaty 1
Amsterdam 1
Auckland 1
Baltimore 1
Bottanuco 1
Brasov 1
Catania 1
Chengdu 1
Chiswick 1
Delhi 1
Dubai 1
Edinburgh 1
Ferrara 1
Formia 1
Hangzhou 1
Hendon 1
Huzhou 1
Iasi 1
Jinhua 1
Lanzhou 1
Lappeenranta 1
Lund 1
Malin 1
Mazara del Vallo 1
Miami Beach 1
Nottingham 1
Olomouc 1
Panama City 1
Paris 1
Totale 4.368
Nome #
Circadian profile of plasma calcitonin gene-related peptide in healthy man 147
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 139
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension 132
null 130
Circadian rhythms of atrial natriuretic peptide, blood pressure and heart rate in normal subjects 123
Effect of ketanserin, an inhibitor of 5-HT2 receptors, on the aldosterone-stimulating action of metoclopramide 120
Stimulatory effect of dermorphin, a new synthetic potent opiate-like peptide, on human growth hormone secretion 119
Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man 118
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 118
Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects 116
Responses of plasma renin activity, aldosterone, adrenocorticotropin, and cortisol to dermorphin, a new synthetic potent opiate-like peptide, in man 112
Cholinergic mediation in dermorphin-induced growth hormone secretion in man 112
Dermorphin inhibits spinal nociceptive flexion reflex in humans 108
Prolactin-Releasing Activity of Dermorphin, a New Synthetic Potent Opiate-Like Peptide, in Normal Human Subjects 107
null 106
null 106
null 106
null 105
Prolactin and growth hormone responses to dermorphin in patients with prolactin-secreting pituitary adenoma 105
Changes of plasma calcitonin gene-related peptide levels in postmenopausal women 105
Growth hormone excess promotes breast cancer chemoresistance 104
Effect of bromocriptine on the control of plasma aldosterone diurnal variation in normal supine man. 102
null 101
DELTA-OPIOID RECEPTOR MODULATION OF THE HYPOTHALAMIC -PITUITARY-ADRENOCORTICAL AXIS 97
Somatostatin Inhibits the Dermorphin-Stimulated Thyrotropin Release in Man 96
Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man 95
Circadian variations of plasma TSH in patients with severe hypothyroidism 95
Maternal plasma calcitonin gene-related peptide levels do not change during labor and are not influenced by delivery route 95
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 94
Acute lowering of plasma GH concentrations by somatostatin is associated with activation of pituitary-adrenal-axisin healthy young and elderly subjects 93
Hormonal replacement therapy affects calcitonin gene-related peptide and atrial natriuretic peptide secretion in postmenopausal women 93
Diurnal rhythm of plasma catecholamines in acromegaly 91
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women 91
null 91
Blood GH-binding protein levels in premenopausal and postmenopausal women: role of body weight and estrogen levels 89
Hypothalamic amenorrhea and cardiovascular hormones: changes of plasma calcitonin gene-related peptide and atrial natriuretic peptide levels 89
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 89
RISK FACTORS FOR DEVELOPING HYPOPITUITARISM AFTER STROKE 88
Delta opioid receptor involvement in endocrine pathophysiology 83
Somatostatin receptor subtype 1 selective activation in human growth hormone- and prolactin-secreting pituitary adenomas: effects on cell viability, growth hormone and prolactin secretion. 83
A defective hypothalamic GHRH activity may contribute to declining GH secretion wuth age in man 83
Pattern of Growth Hormone secretion in closed head injured patients 82
Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: Effects of administration of epinephrine and norepinephrine in healthy man 82
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 78
Pentagastrin does not affect the renin-angiotensin-aldosterone system in man. 76
Human galanin reduces plasma norepinephrine levels in man 75
No acute effect of naloxone and dermorphin on calcitonin secretion in man 70
Failure of metergoline to affect the circadian periodicity of plasma cortisol levels in healthy man 69
Evidence for differential effects of selective somatostatin receptor subtype agonists on alpha-subunit and chromogranin A secretion and on cell viability in human non-functioning pituitary adenomas in vitro 68
The response of TSH and ACTH to pentagastrin in man 67
Somatostatin analogs in vitro effects in a growth hormone-releasing hormone (GHRH)-secreting bronchial carcinoid 64
Plasma aldosterone response to domperidone, an extracerebral dopamine receptor blocker, in normal subjects 63
null 63
null 63
Failure of angiotensin II to affect prolactin concentration in normal women 62
Plasma galanin response to head-up tilt in normal subjects and patients with recurrent vasovagal syncope 62
Circadian rhythm of plasma renin activity 59
Somatostatin reduces 3H thymidine incorporation and c-myc, but not thy-roglobulin RNA levels in human thyroid follicular cells in vitro 59
Effetto della somatostatina in vitro sull'attività dell'adenil-ciclasi e sull'incorporazione di timidina nella tiroide umana 58
null 57
Measurement of human red cell angiotensinase activity by angiotensin II radioimmunoassay 57
Iodine assay in cow milk: Industrial treatments and iodine concentration" 56
In vitro effects of somatostatin on thymidine incorporation and cAMP levels in human thyroid follicles 55
Evidence for circadian variability in the renin angiotensin II system 54
PGH2 blocks the chemosensitizing effects of COX-2 inhibitors by a NF-KB mediated mechanism 54
Role of TSH on the growth and function of autonomous thyroid nodules 54
Study of circadian variations of plasma renin activity in the normal human in the supine position 53
Effetto degli estrogeni sulla crescita dei carcinomi tiroidei differenziati in vitro 51
Effect of domperidone on prolactin secretion in healthy subjects. 51
Gli estrogeni modulano in vitro l'espressione del gene per la tireoglobulina nella tiroide umana normale e neoplastica 50
In vitro effects of somatostatin on human thyroid cells 50
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 49
Inhibitory action of somatostatin on thymidine incorporation in cultures of human thyroid cells 45
Ruolo del TSH sulla crescita e funzione dei noduli tiroidei umani 40
null 37
Differential effects of deltorphin on arginine and galanin-induced growth hormone secretion in healthy man. 22
Effect of human galanin on the response of circulating catecholamines to hypoglycemia in man. 20
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro 19
ENDOCRINE AND GASTROINTESTINAL EFFECTS OF NEUROTENSIN 19
Function of the GH/IGF-I axis in healthy middle aged male runners 18
Stimulation of growth hormone and corticotropin release by angiotensin II in man. 14
Stimulatory effect of angiotensin II upon luteinizing hormone release normal women. 14
Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man 13
Stress-induced activation of sympathetic nervous system is attenuated by the delta-opioid receptor agonist deltorphin in healthy man 13
Effects of somatostatin on human thyroid folliculi in vitro 13
The empty sella syndrome. Clinical, radiological and endocrinologic analysis in 20 cases 10
Totale 6.484
Categoria #
all - tutte 24.444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 801
Totale 25.245


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.244 240 37 37 174 65 146 83 123 74 159 92 14
2020/2021797 86 68 21 101 19 83 15 93 8 93 175 35
2021/2022794 20 70 43 62 33 34 29 32 28 68 82 293
2022/2023838 86 63 39 103 136 120 39 79 99 5 40 29
2023/2024389 33 60 26 6 40 82 11 38 6 7 0 80
2024/202533 33 0 0 0 0 0 0 0 0 0 0 0
Totale 6.484